Wegovy Maker Sues US Pharmacy to Block Knock-Off
Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the
2023-07-07 08:25
China must rethink its reliance on property sales to see real growth
The country's economy was expected to blast out of the blocks after Covid - but that hasn't happened.
2023-07-07 06:22
Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move expected to widen access to
2023-07-07 05:29
Roivant Attracts Interest for $7 Billion-Plus Bowel Drug
Roivant Sciences Ltd. is attracting interest from large pharmaceutical companies for its treatment for inflammatory bowel disease, which
2023-07-07 03:21
Boris Johnson’s WhatsApp Trove Must Be Released, Court Rules
The UK government must comply with an inquiry panel’s demand to disclose all of former Prime Minister Boris
2023-07-06 22:54
Alphabet Exuberance Is Cooling on Wall Street After Stock’s Strong Run
Once one of the highest-rated stocks on Wall Street, Alphabet Inc. is getting a cooler reception from analysts
2023-07-06 21:49
Teva Weighs Sale of $2 Billion Active Ingredients Unit
Teva Pharmaceutical Industries Ltd. is weighing options for its active ingredients business, including a possible sale, people with
2023-07-06 15:54
Companies Play Catch-up as Cybersecurity Attacks Rise in Digital India
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals
2023-07-06 09:28
Threads: Instagram owner launches Twitter-like app
The new app is now available to download in over 100 countries, though not in the European Union.
2023-07-06 07:19
US banks out of favor with European hedge funds, Goldman tells clients
By Carolina Mandl NEW YORK European hedge funds have reduced their exposure to U.S. banks at a fast
2023-07-06 02:57
Tycoon’s Firm Summoned Over Delayed Zimbabwe Platinum Mine
The Zimbabwean government will meet with Bravura Holdings Ltd., a company owned by Nigerian tycoon Benedict Peters, over
2023-07-05 19:52
Moderna Signs Deal to Make mRNA Vaccines for Chinese Market
Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest
2023-07-05 18:48